These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 3168350)

  • 1. Serum HBV-DNA (hepatitis B virus DNA) in acute and chronic hepatitis B infection.
    Feinman SV; Berris B; Fay O; Sooknanan R; Tanno HE; Tung WW; Lieberman HM
    Clin Invest Med; 1988 Aug; 11(4):286-91. PubMed ID: 3168350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus DNA detected by PCR in sera and liver tissues of Chinese patients with chronic liver diseases.
    Zhang YY; Guo LS; Li L; Zhang YD; Hao LJ; Hansson BG; Nordenfelt E
    Chin Med J (Engl); 1993 Jan; 106(1):7-12. PubMed ID: 8504690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Zukeran H
    J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical importance of hepatitis B virus DNA detection in serum of children with chronic hepatitis B].
    Wirth S; Möllers U; Schaefer E; Schwarze U; Zabel B
    Klin Padiatr; 1992; 204(3):155-7. PubMed ID: 1614181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M; Schätzl HM; Zachoval R; Uusi-Oukari M; Lehtovaara P
    Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum HBV DNA and intrahepatic hepatitis B core antigen (HBcAg) in chronic hepatitis B virus infection: correlation with infectivity and liver histology.
    Milani S; Ambu S; Patussi V; D'Agata A; Labardi M; Salvadori G; Surrenti C
    Hepatogastroenterology; 1988 Dec; 35(6):306-8. PubMed ID: 3215627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis B infection in Singapore.
    Yap I; Wee A; Guan R
    Singapore Med J; 1991 Oct; 32(5):352-5. PubMed ID: 1793464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
    G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
    Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
    Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis for the patients with chronic hepatitis B.
    Colić-Cvrlje V; Naumovski-Mihalić S; Prskalo M; Colić A; Cvjeticanin B; Sabarić B
    Coll Antropol; 2000 Jun; 24(1):211-6. PubMed ID: 10895548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different levels of hepatitis B virus replication among hepatitis Be antigen-positive chronic carriers.
    Bartolomé J; Castillo I; Mora I; Gutiez J; Porres JC; Carreño V
    Acta Virol; 1988 May; 32(3):193-7. PubMed ID: 2902767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HBe antigen and B virus DNA in patients with chronic active hepatitis].
    Chaussade S; Thiers V; Boboc B; Housset C; Bréchot C; Degos F
    Gastroenterol Clin Biol; 1986 Nov; 10(11):744-7. PubMed ID: 3803809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic hepatitis B: diagnostic value of hepatitis-B-virus DNA analysis in serum and liver tissue].
    Meier P; Walter E; Blum HE; Offensperger WB; Offensperger S; Schmid M; Gerok W
    Schweiz Med Wochenschr; 1990 Mar; 120(9):310-3. PubMed ID: 2156336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of hepatitis B virus in anti-HBe-positive chronic active type B hepatitis: molecular and immunohistochemical studies.
    Lai MY; Chen DS; Lee SC; Su IJ; Yang PM; Hsu HC; Sung JL
    Hepatogastroenterology; 1988 Feb; 35(1):17-21. PubMed ID: 3360397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.